Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Some codeine behind the counter Down Under

This article was originally published in The Tan Sheet

Executive Summary

Australia's Therapeutic Goods Administration moves codeine-containing nonprescription painkillers from OTC sales to pharmacy only, but leaves cough and cold preparations with the ingredient on store shelves. TGA's National Drugs and Poisons Schedule Committee in June voted to switch codeine products labeled for 100-mg daily dose limit, with no more than 12 mg in individual doses, starting in May 2010 from schedule 2 - nonprescription sales without pharmacist intervention - to schedule 3, which requires distribution by pharmacists. The committee also set a maximum package size of five days' supply for codeine painkillers and for cough/cold preparations labeled for 60-mg maximum daily dose, with no more than 10 mg in each dose. The change follows concerns about codeine abuse, and the committee noted requiring customers to ask pharmacists for the products would help curb inappropriate use. In the U.S., FDA classifies all codeine products as Rx only, while in other countries, including Australia, some drugs containing the ingredient are available OTC or from pharmacists without prescription
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS103265

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel